Leaderboards/Hyperglycemia and glycemic control in critically ill and hospitalized patients

Hyperglycemia and glycemic control in critically ill and hospitalized patients

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Rongting Zhang
Fujian Medical University
2
Kongyong Cui
Chinese Academy of Medical Sciences & Peking Union Medical College
3
Siyuan Cheng
First Affiliated Hospital of Jinan University
4
Zongqing Lu
Anhui Medical University
5
Yixiang Deng
University of Delaware
6
Yingjian Pei
Chinese Academy of Medical Sciences & Peking Union Medical College
7
Side Gao
Beijing Chao-Yang Hospital, Capital Medical University
8
Ivy Shi
Beth Israel Deaconess Medical Center
9
David M. Newland
Seattle Children's Hospital
10
Marcia Roeper
Düsseldorf University Hospital

Papers

1
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021
EP Europace|2024
194 cit.
2
Association between stress hyperglycemia ratio index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study using the MIMIC-IV database
Cardiovascular Diabetology|2024
61 cit.
3
Publication in JAMA Cardiology (2024) [50 citations, W4404470219]
JAMA Cardiology|2024
50 cit.
4
Lactylation of Histone H3k18 and Egr1 Promotes Endothelial Glycocalyx Degradation in Sepsis‐Induced Acute Lung Injury
Advanced Science|2024
50 cit.
5
The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: A national cohort study
Nutrition Metabolism and Cardiovascular Diseases|2024
17 cit.
6
Dapagliflozin Use in Children with Advanced Heart Failure Undergoing Heart Transplantation: A Matched Case-Control Study
Pediatric Cardiology|2024
12 cit.
7
Publication in Journal of Inflammation Research (2025) [4 citations, W4414863733]
Journal of Inflammation Research|2025
4 cit.
8
Publication in Diabetes Obesity and Metabolism (2025) [3 citations, W4410999198]
Diabetes Obesity and Metabolism|2025
3 cit.
9
Publication in Nutrition Metabolism and Cardiovascular Diseases (2025) [2 citations, W4409799259]
Nutrition Metabolism and Cardiovascular Diseases|2025
2 cit.
10
Publication in American Journal of Preventive Cardiology (2025) [2 citations, W4413344539]
American Journal of Preventive Cardiology|2025
2 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ekaterina А. Shestakova
Endocrinology Research Center
2
David C. Klonoff
Mills Peninsula Health Services
3
Valerie Garrett
Centers for Disease Control and Prevention
4
Fang Yong
Fujian Medical University
5
Yuqing Huang
Guangdong Academy of Medical Sciences
6
E. Ferrannini
University of Pisa
7
Zhenhui Zhang
Jiangxi University of Traditional Chinese Medicine
8
Kaijun Zhang
Peking University
9
Gregory P. Forlenza
Diabetes Australia
10
Lia Bally
Diabetes Australia

Papers

1
Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database
Cardiovascular Diabetology|2023
205 cit.
2
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition
Diabetes Mellitus|2022
203 cit.
3
Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients
Cardiovascular Diabetology|2022
185 cit.
4
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes
JAMA|2023
164 cit.
5
Real-World Evidence of Omnipod <sup>®</sup> 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes
Diabetes Technology & Therapeutics|2024
68 cit.
6
Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric <scp>MiniMed</scp> ™ <scp>670G</scp> system trial
Pediatric Diabetes|2022
65 cit.
7
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Diabetes Technology & Therapeutics|2022
65 cit.
8
Perioperative Fully Closed-Loop Insulin Delivery in Patients Undergoing Elective Surgery: An Open-Label, Randomized Controlled Trial
Diabetes Care|2022
44 cit.
9
Association Between Wait Time of Central Venous Pressure Measurement and Outcomes in Critical Patients With Acute Kidney Injury: A Retrospective Cohort Study
Frontiers in Public Health|2022
27 cit.
10
Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study
Cardiovascular Diabetology|2023
27 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Roger Bouillon
KU Leuven
2
Guillermo E. Umpierrez
Emory University
3
Greet Van den Berghe
KU Leuven
4
Grant D. Huang
Department of Veterans Affairs
5
Abbas E. Kitabchi
University of Tennessee Health Science Center
6
Charles A. Stanley
Children's Hospital of Philadelphia
7
J. Geoffrey Chase
University of Canterbury
8
Jane E. Harding
University of Auckland
9
Stephen R. Bloom
Imperial College London
10
Dario Giugliano
University of Campania "Luigi Vanvitelli"

Papers

1
Intensive Insulin Therapy in Critically Ill Patients
New England Journal of Medicine|2001
10k cit.
2
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
New England Journal of Medicine|2008
4.8k cit.
3
Intensive Insulin Therapy in the Medical ICU
New England Journal of Medicine|2006
3.7k cit.
4
Ghrelin Enhances Appetite and Increases Food Intake in Humans
The Journal of Clinical Endocrinology & Metabolism|2001
2.4k cit.
5
Gut hormone PYY3-36 physiologically inhibits food intake
Nature|2002
2.3k cit.
6
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
JAMA|2004
2.1k cit.
7
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
The Journal of Clinical Endocrinology & Metabolism|2002
2.1k cit.
8
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
Circulation|2002
2k cit.
9
GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN
The Lancet|1987
1.9k cit.
10
Early versus Late Parenteral Nutrition in Critically Ill Adults
New England Journal of Medicine|2011
1.7k cit.

Reagents for Hyperglycemia and glycemic control in critically ill and hospitalized patients

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

E2F4 (E3G2G) Rabbit Monoclonal Antibody

#40291$161,351
View Evidence →
Cell Signaling TechnologyEvidence 66

KEAP1 (P586) Antibody

#4678$359
View Evidence →
Cell Signaling TechnologyEvidence 67

TBK1/NAK Antibody

#3013$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

FosB Antibody

Cited in 5 papers
#2263$317
View Evidence →
Cell Signaling TechnologyEvidence 66

SRC-3 (11B1) Mouse Monoclonal Antibody

#2115$158,348
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-S6 Ribosomal Protein (Ser240/244) Antibody

#2215$366
View Evidence →